Tax shift may sock S.F. biotech startups

San Francisco's switch to a gross receipts tax — sweeping into the city treasury a portion of biotech companies' nonprofit grants as well as funding from R&D partnerships — threatens to undo much of the city's work over the past decade to establish itself as a biotech hub...